Examples of 3F Therapeutics in a sentence
Neither ATS Medical nor any such Related Person has acquired any 3F Therapeutics Securities in contemplation of the Merger, or otherwise as part of a plan of which the Merger is a part.
No income, gain or loss will be recognized by ATS Medical, Seabiscuit Acquisition Corp., or 3F Therapeutics as a result of the consummation of the Merger.
Prior to the Merger, ATS Medical will be in control of Seabiscuit, and following the Merger, ATS Medical will be in control of 3F Therapeutics, within the meaning of Section 368(c) of the Code.
The adoption of this Plan shall not affect any other compensation plans in effect for the Company or any Affiliate, nor preclude the Company or any Affiliate from establishing any other compensation plan.
To the extent that a 3F Therapeutics stockholder receives cash in lieu of a fractional share of ATS Medical common stock, the stockholder will be deemed to have received that fractional share in the Merger and then to have received the cash in redemption of that fractional share.
Following the Merger, 3F Therapeutics will hold at least 90 percent of the fair market value of 3F Therapeutics's net assets and at least 70 percent of the fair market value of 3F Therapeutics's gross assets and at least 90 percent of the fair market value of Seabiscuit's net assets and at least 70 percent of the fair market value of Seabiscuit's gross assets held immediately prior to the Effective Time.
The holding period of the shares of ATS Medical common stock received by a 3F Therapeutics stockholder in the Merger (other than shares of ATS Medical common stock taxable as imputed interest income) will include the holding period of the shares of 3F Therapeutics common stock surrendered in exchange therefore.
A portion of the ATS Medical common stock distributed to each 3F Therapeutics stockholder from the escrow or upon the achievement of a milestone (if any) will be taxable on receipt as imputed interest income under the Code.
This gain or loss generally will be long-term capital gain or loss if the holding period for those shares of 3F Therapeutics stock is more than one year as of the date of the Merger.
Within 30 days of the date hereof, Borrower shall cause each of 3F Therapeutics, Inc., a California corporation (“3F”), and ATS Acquisition Corp.